Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-030771

Senior Vice President and CFO sold 3,150 shares at $7.45 ($23,468)

  • Senior Vice President and CFO acquired 3,150 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-10-19 Exercise or conversion : show line 1 in the form +3,150 $3.78 $11,907 140,533 D
2018-10-19 Sale : show line 2 in the form −3,150 $7.45 $23,468 137,383 D
Open-market sales · 3,150 sh · avg $7.45 · $23,468

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-10-19 Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) −3,150 49,305 D
Loading xslF345X03/form4.xml…